By Nicholas Hatcher
Eli Lilly Chief Executive David Ricks said manufacturing of certain drugs could come back to the U.S. if there is an economic incentive, such as lower tax rates for domestic production.
"We favor carrots not sticks and would really like to see the tax bill passed, which would make permanent low tax rates in the U.S.," Ricks said Thursday on CNBC. "Particularly as the president says, 15% for domestic production would be one of the best in the world."
"The threat of tariffs is already bringing back critical supply chains in two important industries: chips and pharma," Ricks said Thursday.
The drugmaker reported surging quarterly revenue Thursday, on steady sales of Mounjaro and other weight-loss treatments. Adjusted earnings topped analyst estimates.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
May 01, 2025 08:00 ET (12:00 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.